Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Multiple sclerosis: Quadrivalent HPV vaccination does not increase risk of MS.
Immunoenrichment microwave & magnetic (IM(2) ) proteomics for quantifying CD47 in the EAE model of multiple sclerosis.
Rabies encephalomyelitis vs. ADEM: Usefulness of MR imaging in differential diagnosis.
First case report of acute hemorrhagic leukoencephalitis following Plasmodium vivax infection.
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis.
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica.
Specialized housing and transportation needs of adults with multiple sclerosis.
Medication possession ratio: implications of using fixed and variable observation periods in assessing adherence with disease-modifying drugs in patients with multiple sclerosis.
Fabry disease - underestimated in the differential diagnosis of multiple sclerosis?
Evolution of tumefactive lesions in multiple sclerosis: A 12-year study with serial imaging in a single patient.
Microcystic Macular Edema: Retrograde Maculopathy Caused by Optic Neuropathy.
Variability in the Cross-Sectional Area and Narrowing of the Internal Jugular Vein in Patients Without Multiple Sclerosis.
Demyelinating CNS Lesions in a Teenager.
Myelin-reactive antibodies initiate T cell-mediated CNS autoimmune disease by opsonization of endogenous antigen.
Multiple Sclerosis and Antibodies against KIR4.1.
No evidence for an association of osteopontin plasma levels with disease activity in multiple sclerosis.
Regional hippocampal involvement and cognitive impairment in pediatric multiple sclerosis.
[Release-active antibodies to S100 protein are able to improve the experimental allergic encephalomyelitis].
High avidity chimeric monoclonal antibodies against the extracellular domains of human aquaporin-4 competing with NMO-IgG.
Effects of diazoxide in multiple sclerosis: A randomized, double-blind phase 2 clinical trial.
Multiple sclerosis relapse phenotype is an important, neglected determinant of disease-outcome: Commentary.
Bladder and bowel dysfunction affect quality of life. A cross sectional study of 60 patients with aquaporin-4 antibody positive Neuromyelitis Optica spectrum disorder.
Multimodal neurophysiological evaluation of primary progressive multiple sclerosis - An increasingly valid biomarker, with limits.
Brain and cord myelin water imaging: a progressive multiple sclerosis biomarker.
[MELATONIN TREATMENT OF AUTOIMMUNE AND ALLERGIC PATHOLOGY].
Pages
« first
‹ previous
…
556
557
558
559
560
561
562
563
564
…
next ›
last »